MarketCapExport financials
Freeline Therapeutics Holdings plc (FRLN)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Freeline Therapeutics Holdings plc Balance Sheet 2022-2011 | FRLN
Brief overview of Freeline Therapeutics Holdings plc's assets and capital
Balance sheet changes are traced across five available annual reports between 2018 and 2022.
Assets rose from $32.1 million to $86.6 million, a gain of +169.6%, while CAGR was about 28.1%. The balance sheet expanded rapidly.
Liabilities expanded faster than the asset base, +273.5% versus +169.6%. Debt-service capacity deserves attention.
Internal capital represents 60.5% of the balance sheet, previously 71.5%. This is a strong capital position.
The period ended with net cash: net debt stood at -$41.4 million. This supports financial flexibility.
Cash equals 54.6% of the balance sheet, compared with 50% five periods ago. This is the readily available cushion.
The accumulated result is -$445.4 million and remains below zero. The number alone does not explain whether losses, dividends or repurchases were the main cause.
Overall assessment
Freeline Therapeutics Holdings plc retains a reasonably healthy balance sheet structure, which still needs support from earnings and cash flow.
Annual Balance Sheet Freeline Therapeutics Holdings plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-41.4 M | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt |
3.26 M | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
2.66 M | - | - | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
31 M | 20.7 M | 18.8 M | 12.4 M | - | - | - | - | - | - | - | - |
Total Liabilities |
34.2 M | 20.7 M | 18.8 M | 12.4 M | 9.16 M | - | - | - | - | - | - | - |
Retained Earnings |
-445 M | -356 M | -216 M | -120 M | -65.8 M | - | - | - | - | - | - | - |
Total Assets |
86.6 M | 141 M | 269 M | 97.4 M | 32.1 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
47.3 M | 118 M | 230 M | 73.7 M | 16.1 M | - | - | - | - | - | - | - |
Book Value |
52.4 M | 120 M | 250 M | 85 M | 23 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
52.4 M | 120 M | 250 M | 85 M | 23 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Freeline Therapeutics Holdings plc
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.7 M | 1.96 M | 2.64 M | 3.26 M | 9.08 M | 46.4 M | 52.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
19.2 M | 20.6 M | 25.4 M | 34.2 M | 31.5 M | 72.5 M | 77.6 M | 20.7 M | 18 M | 15.4 M | 15.8 M | 18.8 M | - | 21.5 M | - | 12.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-472 M | -460 M | -444 M | -445 M | -422 M | -407 M | -383 M | -356 M | -322 M | -291 M | -251 M | -216 M | - | -153 M | - | -120 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
49.2 M | 62.7 M | 81.4 M | 86.6 M | 100 M | 162 M | 196 M | 141 M | 171 M | 201 M | 235 M | 269 M | - | 140 M | - | 97.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
29.5 M | 38.8 M | 55.4 M | 47.3 M | 65.8 M | 90 M | 113 M | 118 M | 136 M | 165 M | 196 M | 230 M | 251 M | 107 M | 52.5 M | 73.7 M | - | 55.5 M | - | 16.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
30 M | 42 M | 56 M | 52.4 M | 68.6 M | 89.6 M | 119 M | 120 M | 153 M | 186 M | 219 M | 250 M | - | 119 M | - | 85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
30 M | 42 M | 56 M | 52.4 M | 68.6 M | 89.6 M | 119 M | 120 M | 153 M | 186 M | 219 M | 250 M | - | 119 M | - | 85 M | - | 71.7 M | - | 23 M | - | - | - | 12.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Freeline Therapeutics Holdings plc, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Britain
Israel
Germany
Canada
Russia
Schweiz
